Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma A phase II trial

Cancer

Volumn 89, Issue 4, 2000, Pages 763-768

  Bajetta, Emilio ^a   Stani, Simonetta Chiara ^a   De Candis, Daniela ^a   Bidoli, Paolo ^a   Mariani, Luigi ^a   Zilembo, Nicoletta ^a   Pozzi, Paola ^a   Procopio, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Chemotherapy; Gemcitabine; Nonsmall cell lung carcinoma (NSCLC); Vinorelbine

Indexed keywords

GEMCITABINE; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 0034663184     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000815)89:4<763::AID-CNCR7>3.0.CO;2-F     Document Type: Article

References (18)

1. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
2. New agents in the management of advanced non-small cell lung cancer
3. In situ analysis of the action of navelbine on various types of microtubules using immunofluorescence
4. Update: Vinorelbine (Navelbine) in non-small cell lung cancer
5. Clinical and preclinical activity of 2', 2'-difluorodeoxycytidine (gemcitabine)
6. Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
7. Gemcitabine: Single-agent and combination therapy in non-small cell lung cancer
8. Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): A phase I trial
9. Optimal two-stage design for phase II clinical trials
10. Confidence limits for probability of response in multistage phase II cancer trials
11. Non parametric estimation from incomplete observations
12. Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial
13. Single agent versus combination chemotherapy in patients with advanced nonsmall cell carcinoma: A meta-analysis of response, toxicity, and survival
14. Rationale of a phase III study comparing a standard cisplatin regimen (mytomicin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer
15. Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced non-small cell lung cancer
16. Paclitaxel plus carboplatin in advanced non-small cell lung cancer: A phase II trial
17. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
18. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer